Hyper Insight™ – ICH Plus
Hyper Insight™ Stroke AI
One platform across the stroke pathway — hemorrhage, infarction, aneurysm, perfusion and 3D vascular imaging, on CT and MR. One solution is FDA-cleared today; seven more are in the FDA process. Select any solution for its description, capabilities, and performance evidence.
Hyper Insight™ – ICH Plus
Detects and localizes suspected acute intracerebral hemorrhage on non-contrast brain CT, with probability scores, ROI visualization and volume quantification.
- Comprehensive hemorrhage detection — all ICH types, no accuracy loss
- AI probability mapping — highlighted regions with confidence scores
- Quantitative volume analysis
- Worklist prioritization (golden-time advantage)
- Instant specialist notification
- Mobile AI DICOM viewer
- Intuitive reporting
Click to zoomKorea multi-center external validation — npj Digital Medicine 2023 (six institutions, 49,841 patients): Accuracy 0.977 · Sensitivity 0.944 · Specificity 0.982 · AUC 0.992. 6,442 patients showed acute hemorrhage. Sensitivity by subtype: SAH 0.954 · SDH 0.933 · EDH 0.933 · IVH 0.994 · IPH 0.977. Accuracy by scanner: GE 0.98 · Philips 0.95–0.99 · Siemens 0.94–0.98 · Toshiba 0.99.
Blinded multi-reader crossover study — nine reviewers across three expertise tiers. All reviewers: Sensitivity 94.4→97.2% · Specificity 95.0→96.9% · Accuracy 94.7→97.0%. By group: non-radiologists 91.9→95.1% · radiologists 94.6→97.4% · neuroradiologists 97.6→98.7%.
- Indicated for adult and pediatric patients, including patients under 18 years of age.
- The largest external validation disclosed in the category — 49,841 patients across six institutions and four scanner families.